Oxidant stress and cardiovascular absolute risk in Tunisian type 2 diabetes;Stress oxydant et risque cardiovasculaire absolu chez des diabétiques de type 2 du centre Tunisien

Annales de Biologie Clinique

Volumn 66, Issue 2, 2008, Pages 151-156

  Kassab, A ^a   Leban, N ^b   Ferchichi, S ^a   Feki, M ^c   Limem, H Ben ^a   Chaeib, L ^a   Miled, A ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

Author keywords

Cardiovascular risk; Diabetes; Homocysteine; Microalbuminuria; Oxidant stress

Indexed keywords

EID: 42449091175     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2008.0203     Document Type: Article

References (23)

1. Giampaoli S, Palmieri L, Mattiello A, Panico S. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis 2005 ; 15 : 79-85.
2. Willson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998 ; 97 : 1837-47.
3. Laurier D, Nguyen PC, Cazelles B, Segond P. Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group. J Clin Epidemiol 1994 ; 47 : 1353-64.
4. Marrugat J, D'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003 ; 57 : 634-8.
5. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002 ; 105 : 310-5.
6. Conroy RM, Pyorala K, Fitzgerald AP, et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe : The SCORE project. Eur Heart J 2003 ; 24 : 987-1003.
7. Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005 ; 40 : 1215-20.
8. Garanty-Bogacka B, Syrenicz M, Szolomicka-Kurzawa P, Gebala A, Goral J, Krupa B. Correlation between serum homocysteine levels and selected atherosclerosis risk factors in children and adolescents with simple obesity. Przel Lek 2006 ; 63 : 645-9.
9. Mayaudon H, Dupuy O, Bordier L, Sarret D, Bauduceau B. Calculation of the absolute cardiovascular risk in practice. Diabetes Metab 2001 ; 27 : 82-6.
10. Gillery P. Stress oxydant et glycation des protéines au cours du diabète sucré. Ann Biol Clin (Paris) 2006 ; 64 : 309-14.
11. www.hegp.bhdc.jussieu.fr/esper.
12. Lefèvre G, Beljean-Leymarie M, Beyerle F, et al. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Ann Biol Clin (Paris) 1998 ; 56 : 305-19.
13. Driskell WJ, Neese JW, Bryant CC, Bashor MM. Measurement of vitamin A and vitamin E in human serum by high-performance liquid chromatography. J Chromatogr 1982 ; 231 : 439-44.
14. Soinio M, Marniemi J, Laakso M, Lento S, Rönnemaa T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 2004 ; 140 : 94-100.
15. Vangelder E, Delecourt F, Cardozo M-B, Dhondt J-L, Forzy G. Hyperhomocystéinémie et diabète de type 2. Ann Biol Clin (Paris) 2006 ; 64 : 485-9.
16. Hayden MR, Tyagi SC. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy : the pleiotropic effects of folate supplementation. Nutr J 2004 ; 3 : 4-27.
17. Garalienė V. The main determinants of endothelial dysfunction. Medicina (Kaunas) 2006 ; 42 : 362-9.
18. Gardner R, Salvador A, Moradas-Ferreira P. Why does SOD overexpression sometimes enhance, sometimes decrease, hydrogen peroxide production ? A mini-malist explanation. Free Radic Biol Med 2002 ; 32 : 1351-7.
19. Spiteller G. The relation of lipid peroxidation processes with atherogenesis : a new theory on atherogenesis. Mol Nutr Food Res 2005 ; 49 : 999-1013.
20. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993 ; 84 : 407-12.
21. Mann JF, Yi QL, Gerstein HC. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int Suppl 2004 ; 92 : S59-S62.
22. Helaly MA, Sheashaa HA, Hatata el SZ, Youssef AB, Hegazi A, Abdel-Aal IA. Endothelial dysfunction in geriatric diabetic patients : the role of microalbuminuria in elderly type 2 diabetic patients ? A randomized controlled study. Int Urol Nephrol 2007 ; 39 : 333-8.
23. Arnal JF, Laurell H, Leufant F, Douin-Echinard V, Brauchet L, Gourdy P. Estradiol action in atherosclerosis and reendothelialization. Ernst Schering Found Symp Proc 2006 ; 1 : 69-86.